Logo image of SPCE

VIRGIN GALACTIC HOLDINGS INC (SPCE) Stock Fundamental Analysis

NYSE:SPCE - New York Stock Exchange, Inc. - US92766K4031 - Common Stock - Currency: USD

2.905  -0.09 (-2.84%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SPCE. SPCE was compared to 66 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of SPCE have multiple concerns. While showing a medium growth rate, SPCE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SPCE had negative earnings in the past year.
In the past year SPCE has reported a negative cash flow from operations.
SPCE had negative earnings in each of the past 5 years.
SPCE had a negative operating cash flow in each of the past 5 years.
SPCE Yearly Net Income VS EBIT VS OCF VS FCFSPCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

SPCE's Return On Assets of -36.42% is on the low side compared to the rest of the industry. SPCE is outperformed by 77.27% of its industry peers.
The Return On Equity of SPCE (-120.96%) is worse than 77.27% of its industry peers.
Industry RankSector Rank
ROA -36.42%
ROE -120.96%
ROIC N/A
ROA(3y)-40.85%
ROA(5y)-47.15%
ROE(3y)-103.71%
ROE(5y)-94.59%
ROIC(3y)N/A
ROIC(5y)N/A
SPCE Yearly ROA, ROE, ROICSPCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

SPCE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPCE Yearly Profit, Operating, Gross MarginsSPCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K -200K -250K

More info and screens

3

2. Health

2.1 Basic Checks

SPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
SPCE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SPCE has been reduced compared to 5 years ago.
SPCE has a worse debt/assets ratio than last year.
SPCE Yearly Shares OutstandingSPCE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SPCE Yearly Total Debt VS Total AssetsSPCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SPCE has an Altman-Z score of -4.59. This is a bad value and indicates that SPCE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SPCE (-4.59) is worse than 86.36% of its industry peers.
SPCE has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
SPCE has a Debt to Equity ratio of 1.55. This is amonst the worse of the industry: SPCE underperforms 80.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z -4.59
ROIC/WACCN/A
WACC5.2%
SPCE Yearly LT Debt VS Equity VS FCFSPCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.81 indicates that SPCE has no problem at all paying its short term obligations.
SPCE has a Current ratio of 3.81. This is in the better half of the industry: SPCE outperforms 78.79% of its industry peers.
A Quick Ratio of 3.81 indicates that SPCE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.81, SPCE belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 3.81
SPCE Yearly Current Assets VS Current LiabilitesSPCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

SPCE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.08%, which is quite impressive.
The Revenue for SPCE has decreased by -34.33% in the past year. This is quite bad
Measured over the past years, SPCE shows a quite strong growth in Revenue. The Revenue has been growing by 13.23% on average per year.
EPS 1Y (TTM)59.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.4%
Revenue 1Y (TTM)-34.33%
Revenue growth 3Y28.84%
Revenue growth 5Y13.23%
Sales Q2Q%-76.78%

3.2 Future

The Earnings Per Share is expected to grow by 15.72% on average over the next years. This is quite good.
The Revenue is expected to grow by 170.64% on average over the next years. This is a very strong growth
EPS Next Y28.53%
EPS Next 2Y22.6%
EPS Next 3Y23.6%
EPS Next 5Y15.72%
Revenue Next Year-56.47%
Revenue Next 2Y328.1%
Revenue Next 3Y277.03%
Revenue Next 5Y170.64%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SPCE Yearly Revenue VS EstimatesSPCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SPCE Yearly EPS VS EstimatesSPCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SPCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SPCE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPCE Price Earnings VS Forward Price EarningsSPCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPCE Per share dataSPCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

SPCE's earnings are expected to grow with 23.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.6%
EPS Next 3Y23.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SPCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIRGIN GALACTIC HOLDINGS INC

NYSE:SPCE (6/23/2025, 12:07:00 PM)

2.905

-0.09 (-2.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners26.86%
Inst Owner Change-73.81%
Ins Owners0.58%
Ins Owner Change0.43%
Market Cap120.76M
Analysts50.67
Price Target9.48 (226.33%)
Short Float %29.89%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.82%
Min EPS beat(2)13.07%
Max EPS beat(2)20.56%
EPS beat(4)4
Avg EPS beat(4)26.55%
Min EPS beat(4)13.07%
Max EPS beat(4)36.28%
EPS beat(8)8
Avg EPS beat(8)23.05%
EPS beat(12)8
Avg EPS beat(12)10.19%
EPS beat(16)9
Avg EPS beat(16)6.04%
Revenue beat(2)1
Avg Revenue beat(2)-33.93%
Min Revenue beat(2)-80.85%
Max Revenue beat(2)12.99%
Revenue beat(4)1
Avg Revenue beat(4)-58.14%
Min Revenue beat(4)-82.35%
Max Revenue beat(4)12.99%
Revenue beat(8)3
Avg Revenue beat(8)-26.61%
Revenue beat(12)6
Avg Revenue beat(12)53.9%
Revenue beat(16)9
Avg Revenue beat(16)53.16%
PT rev (1m)5.33%
PT rev (3m)4.07%
EPS NQ rev (1m)-0.72%
EPS NQ rev (3m)8.24%
EPS NY rev (1m)2.92%
EPS NY rev (3m)11.65%
Revenue NQ rev (1m)-8.77%
Revenue NQ rev (3m)-35.67%
Revenue NY rev (1m)82.27%
Revenue NY rev (3m)97.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.91
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-10.23
EYN/A
EPS(NY)-6.39
Fwd EYN/A
FCF(TTM)-11.31
FCFYN/A
OCF(TTM)-7.59
OCFYN/A
SpS0.13
BVpS6.55
TBVpS6.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.42%
ROE -120.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.85%
ROA(5y)-47.15%
ROE(3y)-103.71%
ROE(5y)-94.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 968.23%
Cap/Sales 2808.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.81
Quick Ratio 3.81
Altman-Z -4.59
F-Score2
WACC5.2%
ROIC/WACCN/A
Cap/Depr(3y)422.61%
Cap/Depr(5y)296.8%
Cap/Sales(3y)1032.44%
Cap/Sales(5y)2081.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.4%
EPS Next Y28.53%
EPS Next 2Y22.6%
EPS Next 3Y23.6%
EPS Next 5Y15.72%
Revenue 1Y (TTM)-34.33%
Revenue growth 3Y28.84%
Revenue growth 5Y13.23%
Sales Q2Q%-76.78%
Revenue Next Year-56.47%
Revenue Next 2Y328.1%
Revenue Next 3Y277.03%
Revenue Next 5Y170.64%
EBIT growth 1Y25.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.62%
EBIT Next 3Y28.07%
EBIT Next 5Y26.38%
FCF growth 1Y-0.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.95%
OCF growth 3YN/A
OCF growth 5YN/A